Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

SyMap Closes $100 Million Round for Renal Denervation Devices

publication date: Dec 29, 2021

Suzhou SyMap Medical raised nearly $100 million in an E Round financing to conduct clinical trials of its renal denervation devices. The company also announced a strategic collaboration with Israel's Pythagoras Medical that allows SyMap full rights to use all of Pythagoras' assets including its ConfidenHT™ Renal Nerve Mapping System, a device that is approved for use in the EU. SyMap focuses on devices for cardiovascular and pulmonary diseases. Its latest financing, which was concluded earlier this month, is the largest financing for a renal denervation field, according to the company. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital